|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 24 November 2020, 10:38. The announcement is not marked as price sensitive, and is 17 page(s) in length and 1.72MB in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.014% short sold according to ASIC data. It was ranked the 563rd most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| AGM Presentations | 24 November 2020, 10:38 |
| Cynata Technology Featured on Front Cover of Nature Medicine | 18 November 2020, 10:21 |
| Phase 3 Osteoarthritis Clinical Trial Commences | 11 November 2020, 9:39 |
| Quarterly Activity Report & Appendix 4C | 30 October 2020, 10:01 |
You must be logged in to post a reply.
Cynata Therapeutics 